SHR # 2534 :: Efficacy of Glutathione Therapy in Treating COVID-19 Related Pneumonia PLUS 62 And None The Wiser - Dr. Richard Horowitz, MD - Infection with COVID-19 potentially can result in severe outcomes and death from cytokine storm syndrome, resulting in novel coronavirus pneumonia (NCP) with severe dyspnea, acute respiratory distress syndrome (ARDS), fulminant myocarditis and multiorgan dysfunction with or without disseminated intravascular coagulation. No published treatment to date has been shown to adequately control the inflammation and respiratory symptoms associated with COVID-19, apart from oxygen therapy and assisted ventilation. We evaluated the effects of using high dose oral and or IV glutathione in the treatment of 2 patients with dyspnea secondary to COVID-19 pneumonia. PLUS Carl turns 62 tomorrow. Is he older and wiser? Maybe not.